Work

Cross-species spatial profiling links progranulin to an immune suppressive niche in brain metastasis

Year: 2026
Type: preprint
Abstract: Immune checkpoint inhibitors (ICI) have revolutionized the treatment of brain metastasis (BM), demonstrating intracranial response rates and durability not previously seen with other therapies. However, approximately 50% of patients do not respond to ICI, and the brain-specific interactions that shape anti-tumor immunity remain poorly understood. We profiled five syngeneic BM models using spatial transcriptomics, identifying myeloid-rich niches enriched for interferon-responsive and disease-associated microglia (DAM)-like programs. Ligand-receptor colocalization analyses identified progranulin (PGRN) as a candidate mediator of these niches. Host- or tumor-cell Grn loss reduced BM burden, and Grn -deficient macrophages exhibited altered metabolic programs and tumor-cell engulfment in vitro. Across independent human BM datasets, GRN expression was associated with conserved lysosomal and DAM-like myeloid programs, and GRN -high myeloid regions colocalized with immunosuppressive signatures and dysfunctional CD8+ T cell states. These cross-species findings identify PGRN as a candidate mediator of the BM immune niche and support further investigation of its therapeutic relevance. Highlights A multi-model spatial atlas resolves myeloid niches in both preclinical models of brain metastases and human patient tissues Host- and tumor-cell progranulin support brain metastatic growth Progranulin associates with lysosomal function and disease-associated myeloid states in brain metastasis Human progranulin-rich myeloid niches colocalize with dysfunctional cytotoxic T cells in brain metastasis Graphical Abstract
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W7213744657
Cites:
Cited by:
Related to: